Results 81 to 90 of about 37,273 (171)
Multivariate analyses between ΔBCVA12 and variables using binarization of the choroid at baseline, 3 and 12 months in polypoidal choroidal vasculopathy (PCV) with intravitreal aflibercept injections.
Jinhee Lee (226004) +8 more
core +1 more source
Mariko Yamashita, Tomo Nishi, Taiji Hasegawa, Nahoko Ogata Department of Ophthalmology, Nara Medical University, Kashihara, Nara, Japan Purpose: To report the effects of aflibercept on eyes with large retinal pigment epithelial detachment (PED ...
Yamashita M +3 more
doaj
Saeed T Alshahrani,1,2 Hanan N Al Shamsi,2 Eman S Kahtani,2 Nicola G Ghazi2,3 1King Fahad Specialist Hospital, Dammam, Saudi Arabia; 2King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 3University of Virginia, Department of Ophthalmology ...
Alshahrani ST +3 more
doaj
Mario R Romano1, Ugo Cipollone2, Francesco Semeraro3, Michele Rinaldi4, Ciro Costagliola11Dipartimento di Scienze per la Salute, Università degli Studi del Molise, Campobasso; 2Dipartimento di Oftalmologia, Ospedale G Vietri, Larino ...
Mario R Romano +3 more
doaj
Purpose: To evaluate the angiographic features in using fundus camera-based versus confocal scanning laser ophthalmoscope (cSLO)-based indocyanine green angiography in differentiating polypoidal choroidal vasculopathy (PCV) from typical age-related ...
core
Dissecting the angiogenic mechanism of pachychoroid polypoidal choroidal vasculopathy. [PDF]
Zhao X +18 more
europepmc +1 more source
Management of polypoidal choroidal vasculopathy: Malaysian Consensus Guideline 2023. [PDF]
Ngah NF +14 more
europepmc +1 more source
Severe Polypoidal Choroidal Vasculopathy as a Harbinger of Spontaneous Suprachoroidal Hemorrhage. [PDF]
Tao BK +7 more
europepmc +1 more source
Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg. [PDF]
Sherif MZ +6 more
europepmc +1 more source
Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]
Koh A +6 more
europepmc +1 more source

